Also trades as: METROPOLIS.NS (NSE) · $vol 1M
METROPOLIS.BO BSE
Metropolis Healthcare Limited
1W: -1.8%
1M: +9.9%
3M: -72.7%
YTD: -73.5%
1Y: -65.2%
3Y: -60.4%
5Y: -75.4%
₹518.90 ($5.43)
-9.45 (-1.79%)
Weekly Expected Move ±5.0%
₹483
₹510
₹536
₹563
₹589
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹109.5B ($1.1B)
52W Range400.75-599.9
Volume8,351
Avg Volume43,302
Beta0.79
Dividend₹2.00
Analyst Ratings
No analyst coverage
Company Info
CEOSurendran Chemmenkotil
Employees4,313
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2019-04-15
Websitemetropolisindia.com
250-D, Udyog Bhavan
Mumbai 400030
IN
Mumbai 400030
IN
91 22 6258 2810
About Metropolis Healthcare Limited
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, and diagnosis of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found